Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06620159
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Lymphocyte to Procalcitonin Ratio A New Predictor of Prognosis and Mortality in Covid
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The lymphocyteCRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis In this study the role of the lymphocyteprocalcitonin ratio in predicting the hospitalization status of patients detection of findings on CT need for mechanical ventilation mortality and survival is aimed to be determined The lymphocyteprocalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis especially in patients over 65 years of age
Detailed Description:
The lymphocyteCRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis In this study the role of the lymphocyteprocalcitonin ratio in predicting the hospitalization status of patients detection of findings on CT need for mechanical ventilation mortality and survival is aimed to be determined The lymphocyteprocalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis especially in patients over 65 years of age The auc value PPV and specificity of the lymphocyteprocalcitonin ratio were higher than the lymphocyteCRP ratio
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None